Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging
由于术前分期不准确，新辅助放化疗对临床分期为T2N0的食管癌患者是有益的。
期刊:Annals of Thoracic Surgery
影响因子:3.9
doi:10.1016/j.athoracsur.2011.10.061
Zhang, Jennifer Q; Hooker, Craig M; Brock, Malcolm V; Shin, James; Lee, Sue; How, Remealle; Franco, Noreli; Prevas, Helen; Hulbert, Alicia; Yang, Stephen C
